ARS Pharmaceuticals Announces Key Executive Leadership DeparturesTip Ranks·Jul 17 at 04:36 PMSPRY-1.00%
Richard Lowenthal resigns from ARS Board; Sarina Tanimoto departs as CMOTradingView·Jul 17 at 03:03 PMSPRY-1.00%
M&A and Restructuring Surge Accelerates Across US Small-CapsGlobal Report·Jul 15 at 04:14 AMCHRD-0.38%TGHL+4.73%
17:35 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRYprnewswire·Jul 9 at 04:38 PMSPRY-1.00%
14:00 ETARS Pharmaceuticals (SPRY) Securities Fraud Investigation - Levi & Korsinskyprnewswire·Jul 6 at 01:02 PMSPRY-1.00%
13:25 ETARS Pharmaceuticals Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of ARS Pharmaceuticals (SPRY)prnewswire·Jun 29 at 12:27 PMSPRY-1.00%
SPRY Investors Have Opportunity to Join ARS Pharmaceuticals, Inc. Fraud Investigation with the Schall Law FirmMorningStar·Jun 28 at 11:09 AMSPRY-1.00%
